The vav locus was first identified by virtue of its oncogenic activation during the course of gene transfer assays with human tumor DNA (32). Molecular characterization of this oncogene allowed the isolation and characterization of its normal allele, the vav proto-oncogene. This gene encodes a 95-kDa polypeptide, designated Vav, that contains an array of structural motifs suggestive of a role in signaling pathways (40). These motifs include an amino-terminal leucine-rich region (13), a Dbl homology (DH) motif similar to sequences present in regulators of the Rho/CDC42 family of small GTP-binding proteins (6), a pleckstrin homology (PH) domain (37), a cysteine-rich region which displays strong similarity to the zincbutterfly domains of protein kinase C isoforms (13), and two C-terminal SH3 motifs flanking a single SH2 domain (9, 35) .
The vav locus was first identified by virtue of its oncogenic activation during the course of gene transfer assays with human tumor DNA (32) . Molecular characterization of this oncogene allowed the isolation and characterization of its normal allele, the vav proto-oncogene. This gene encodes a 95-kDa polypeptide, designated Vav, that contains an array of structural motifs suggestive of a role in signaling pathways (40) . These motifs include an amino-terminal leucine-rich region (13) , a Dbl homology (DH) motif similar to sequences present in regulators of the Rho/CDC42 family of small GTP-binding proteins (6) , a pleckstrin homology (PH) domain (37) , a cysteine-rich region which displays strong similarity to the zincbutterfly domains of protein kinase C isoforms (13) , and two C-terminal SH3 motifs flanking a single SH2 domain (9, 35) .
Several studies have suggested a role of vav in signal transduction. Overexpression and/or mutations in the Vav protein lead to morphologic transformation and deregulated cell growth of NIH 3T3 cells (13, 31, 32) . Biochemical studies have shown that Vav becomes tyrosine phosphorylated upon stimulation of a variety of hematopoietic receptors responsible for mediating proliferative as well as differentiation signals. They include the T-cell receptor (TCR)-CD4 complex (9, 35) , the mast cell immunoglobulin E high-affinity receptor (35) , the B-cell immunoglobulin M antigen complex (8) , the c-Kit and Flk-2 tyrosine kinase receptors (4, 15) , and the interleukin-2 and alpha interferon receptors (17, 39) . More recently, genetargeting experiments have revealed that ablation of the vav locus in embryonic stem cells results in early lethality of homozygous mouse embryos (51) .
Little is known regarding the downstream elements that mediate Vav signaling. Vav contains an amino-terminal leucine-rich domain whose deletion results in the activation of its mitogenic activity (13, 31, 32) . However, it is not clear whether these sequences are responsible for the interaction of Vav with signaling partners. Vav also contains a region with high homology to the Dbl oncoprotein (2) . Demonstration that Dbl has GDP/GTP exchange activity for members of the Rho family of small GTP-binding proteins (26) has fueled the speculation that Vav might also be an activator of these types of molecules. Indeed, Gulbins and coworkers have published a series of papers claiming that Vav is a Ras GDP/GTP exchange factor (22) (23) (24) . These observations, however, have not been reproduced by either us (11) or other investigators (33) .
Circumstantial evidence indicates that protein-protein interactions might play an important role in the regulation of Vav activity. Indeed, most of the structural motifs present in Vav have been shown to be implicated in the formation of heterogeneous molecular complexes, including the PH domain (37) and, particularly, the SH3 and SH2 domains (41) . In agreement with this hypothesis, it has been previously shown that the Vav SH2 domain allows the association of Vav with ligandstimulated tyrosine kinase receptors (9, 35) and with other molecules upon stimulation of hematopoietic receptors (8) . Moreover, mutations affecting conserved residues in the Vav SH2 domain critically impair the transforming activity of the protein, an indication that this region is essential for the proper biological activity of the Vav oncoprotein (30) .
We undertook these studies to identify proteins capable of physically associating with Vav. To this end, we took advantage of the yeast two-hybrid system, a genetic approach that allows detection of in vivo interactions via the reconstitution of a functional transcriptional activator (18) . In this report we describe the identification of the human heterogeneous nuclear ribonucleoprotein K (hnRNP K) and a novel 45-kDa poly(rC)-binding protein as molecules that specifically interact with the SH3-SH2-SH3 region of Vav.
MATERIALS AND METHODS
Plasmids. Yeast pGBT derivatives included those containing the mouse Vav SH3-SH2-SH3 region (residues 610 to 845; pXRB26), the amino-terminal domain of human c-RAF (residues 1 to 157; pXRB37), full-length mouse Grb-2 (pMLB12), and the Ack SH3 domain (residues 441 to 510; pGBTAckSH3). pGAD-GH derivatives included those encoding the proline-rich region of mouse Sos (residues 1139 to 1333; pMLB20) and the human wild-type (pXRB33) and oncogenic (pXRB36) RAS proteins devoid of their carboxy-terminal farnesylation sites. pXRB55 contains residues 171 to 463 of the human hnRNP K protein.
Plasmids encoding the yeast SNF1 and SNF4 proteins have been described elsewhere (5) . Bacterial expression vectors included pKLS26, a pGEX-2TK derivative containing the Vav SH3-SH2-SH3 region (residues 611 to 845); pKLS3, a pGEX-2T derivative containing the Vav SH2 domain (residues 655 to 774); pKLS48, a pGEX-2TK derivative containing the N-terminal Vav SH3 domain (residues 611 to 749); pXRB14, a pGEX-3X derivative containing the carboxy-terminal Vav SH3 motif (residues 748 to 845); and pXRB24, a pGEX-2T derivative containing residues 788 to 1244 of the rat CDC25 Ras GDP/GTP exchange factor. pGEX-5X-1 derivatives included plasmids containing residues 171 to 463 (pXRB62), 276 to 459 (pXRB67), 296 to 459 (pXRB68), 317 to 459 (pXRB69), 171 to 298 (pXRB71), and 171 to 278 of hnRNP K as well as residues 249 to 529 of the human hnRNP L protein (pXRB70). Baculovirus vectors included pKLS29, a pBMS-1 derivative (44) containing a glutathione S-transferase (GST)-Vav SH3-SH2-SH3 fusion protein (residues 611 to 845 plus a carboxy-terminal protein kinase A phosphorylation site), and pAZ12, a pVL1393 derivative containing the full-length mouse Vav protein fused to an amino-terminal histidine tag.
Library screening. YBP2 cells were transformed to tryptophan prototrophy with pXRB26 by the alkaline method (29) and used to screen a HeLa cDNA library by standard procedures (5) . Positive clones were preliminarily characterized by manual sequencing with dideoxy nucleoside triphosphates and Sequenase 2.0 (Amersham) according to the manufacturer's specifications. Further sequencing was accomplished by a Taq polymerase-dye terminator (Perkin-Elmer) PCR amplification technique and subsequent analysis of the labeled fragments with a 373 DNA automatic sequencer (Applied Biosystems).
hnRNP K cDNA cloning. To generate a cDNA clone encoding the full-length human hnRNP K protein, we amplified the missing 5Ј end of pXRB55 from a HeLa cDNA library with oligonucleotides 5ЈCCGGCGGCCGTGTCAGTTGT TGGTCCGACCCAGAACGC3Ј and 5ЈGGTCTCCAGGTCTCCCTCTTCTGT CATAGGCCATGAGG3Ј as 5Ј and 3Ј amplimers, respectively. The PCR fragment was purified, digested with EagI (present in the 5Ј amplimer [underlined] and in the coding sequences of hnRNP K), and ligated into EagI-linearized pXRB60, a pBluescript SK derivative containing the truncated cDNA insert of pXRB55, to generate pXRB74. The full-length hnRNP K cDNA was liberated from pXRB74 by BssHII digestion, blunt ended with T4 DNA polymerase, and ligated into SmaI-linearized pMEX expression vector to generate pXRB75 (correct orientation) and pXRB76 (reverse orientation). pXRB77, a pMEX derivative lacking most of the 3Ј noncoding region of hnRNP K cDNA, was generated by EcoRI digestion of pXRB75 followed by religation. A double mutant hnRNP K protein (I65 and I410 changed to N) defective in RNA binding was described elsewhere (43) . Plasmids were linearized and transfected into NIH 3T3 cells by the calcium phosphate precipitation method (21) .
Cellular synchronization and subcellular fractionation. Exponentially growing B36-212 cells were quiesced by serum withdrawal for 48 h as previously described (9) . To obtain cells in G 1 phase, resting cells were stimulated with 10% calf serum for 4 h. Cells blocked in G 1 /S phase were obtained by stimulating quiescent cells with 10% calf serum for 18 h in the presence of 10 mM hydroxyurea (Sigma). Cells arrested in G 2 /M phase were obtained with 0.4 g of nocodazol (Sigma) per ml as previously described (42) . For subcellular fractionation, B36-212 cells were washed twice in ice-cold phosphate-buffered saline, resuspended in hypotonic lysis buffer (10 mM Tris-HCl [pH 7.9], 10 mM KCl, 1.5 mM MgCl 2 , 0.5 mM dithiothreitol, 1% aprotinin [Sigma], 250 M phenylmethylsulfonyl fluoride) and disrupted by 50 strokes in a glass homogenizer with a loose-fitting pestle. Cytosolic and nuclear fractions were separated by low-speed centrifugation (1,000 ϫ g) at 4ЊC for 5 min. The resulting cytosolic supernatant was withdrawn and cleared by centrifugation at 11,000 ϫ g for 20 min at 4ЊC. The nuclear pellet was washed once in hypotonic buffer and then lysed by being vortexed in the presence of hypotonic buffer containing 1% Triton X-100. Lysed nuclei were centrifuged at 11,000 ϫ g for 20 min at 4ЊC, and the supernant obtained was considered the nuclear fraction.
Antibodies. A polyclonal rabbit antiserum raised against a maltose-binding protein fusion protein containing the DH domain of the mouse Vav protein (residues 181 to 449) was used for immunoprecipitation assays. A rabbit polyclonal antiserum elicited against the cysteine-rich region of Vav (8) was used for Western blot (immunoblot) analysis. A monoclonal antibody against hnRNP K was generated with affinity-purified hnRNP K protein from HeLa cells (36) . Other immunological reagents included monoclonal antibodies against the bacterial GST protein (Santa Cruz) and ␣-tubulin (Oncogene Sciences).
In vitro binding and immunoprecipitation experiments. GST fusion proteins were induced and purified by standard protocols and stored bound to glutathione-Sepharose beads (Pharmacia/LKB) at Ϫ20ЊC. Tissues and cells were resuspended in radioimmunoprecipitation assay buffer (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% Triton X-100, 150 mM NaCl, 1% aprotinin [Sigma], 250 M phenylmethylsulfonyl fluoride, 1 mM sodium fluoride, 100 M sodium orthovanadate), disrupted by either brief sonication (tissues) or vortexing (cells), and centrifuged at 11,000 ϫ g for 30 min at 4ЊC. Clarified supernatants were incubated in the presence of the appropriate GST fusion proteins (1 to 5 g) immobilized to glutathione beads for 2 h at 4ЊC. After incubation, beads were collected by centrifugation and washed four times in a buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, and 0.3% sodium dodecyl sulfate (SDS). Washed beads were resuspended in 1ϫ SDS sample buffer (80 mM Tris-HCl [pH 6.8], 2% SDS, 10% glycerol, 0.5% ␤-mercaptoethanol, 0.02% bromophenol blue), fractionated by SDS-polyacrylamide gel electrophoresis (PAGE), and analyzed by Western blot analysis (see below). For immunoprecipitations, cellular lysates were incubated with the appropriate antibody for 2 to 6 h at 4ЊC. After incubation, immunocomplexes were collected with either protein A-Sepharose (Pharmacia/LKB) or protein G-agarose (Oncogene Sciences). Immunoprecipitates were then washed four times in 10 mM Tris-HCl (pH 8.0)-150 mM NaCl-0.1% Triton X-100, dissolved in 1ϫ SDS sample buffer, and separated by SDS-PAGE. Immunoblot analysis of electrophoretically fractionated proteins was performed as described elsewhere (8) .
Filter blot assays. For Far Western blot analysis, a GST-Vav SH3-SH2-SH3 fusion protein affinity purified from pKLS29-infected Sf9 insect cells was labeled at 37ЊC for 30 min in HMK buffer (20 mM Tris-HCl [pH 7.5], 100 mM NaCl, 12 mM MgCl 2 , 1 mM dithiothreitol) containing 1 Ci of [␥- 32 P]ATP (NEN/DuPont) per liter and 1 U of protein kinase A (Sigma) per l. Labeled proteins were purified from unincorporated ATP by size exclusion chromatography onto Sephadex G-25M (PD-10 columns; Pharmacia/LKB) preequilibrated in HMK supplemented with 0.5% bovine serum albumin, 0.2% Triton X-100, and 5% glycerol. Nitrocellulose-bound proteins were blocked in Tris-buffered saline (TBS) supplemented with 5% Carnation nonfat milk and 0.1% Tween 20. After blocking, 32 P-labeled GST-Vav SH3-SH2-SH3 (100,000 cpm/ml) was added to the same solution and incubated for 4 h at 4ЊC. Filters were finally washed four times in TBS containing 0.05% Tween 20 and 0.1% Nonidet P-40. Northwestern blot analysis was performed as previously described (36) .
RESULTS

Isolation of Vav-binding proteins.
To identify proteins implicated in the Vav signaling pathway, we sought to isolate cDNAs whose products interact with the SH3-SH2-SH3 domains of the mouse Vav protein. Toward this goal, we employed the yeast two-hybrid interaction system originally described by Fields and Song (18) . As a ''bait,'' we fused the Vav SH3-SH2-SH3 region (9) to the Gal4 DNA-binding domain (GBD) in a vector (pGBT) that directs low levels of expression of the GBD fusion proteins. As the tester strain, we used a YPB2 derivative containing the bait plasmid, pXRB26, and two Gal4-inducible markers, HIS3 and lacZ. This tester strain was retransformed with a HeLa cell cDNA library constructed in the pGAD-GH plasmid, a vector that directs the synthesis of fusion proteins containing HeLa cell polypeptides and the Gal4 transcriptional activation domain (GAD). In those cases in which a GAD fusion protein interacts with the GBD-Vav SH3-SH2-SH3 fusion protein, a functional Gal4 activity is reconstituted, leading to histidine prototrophy (HIS3) and ␤-galactosidase expression (lacZ) (18) .
A total of 6 ϫ 10 6 transformants were placed in selective medium containing 5 mM 3-amino-1,2,4-triazole. Those transformants that showed histidine prototrophy after 2 weeks of culture were subsequently screened by a filter lift assay for the ability to produce ␤-galactosidase (7). About 200 His ϩ ␤-galactosidase ϩ colonies were isolated. To test whether their phenotypes were dependent on their interaction with the GBDVav SH3-SH2-SH3 fusion protein, library-derived plasmids were selectively recovered by complementation of the leuB6 mutation of Escherichia coli MH4 and used to transform YBP2 cells expressing either the GBD-Vav SH3-SH2-SH3 bait or an unrelated GBD fusion protein containing the N-terminal region of c-RAF protein.
As indicated in Table 1 , pXRB55, a plasmid containing a 3.0-kbp DNA insert, was capable of activating the GBD-Vav SH3-SH2-SH3 fusion protein. The specificity of this interaction was illustrated by the lack of activation of a related GBD fusion protein containing the full-length Grb-2, a protein whose SH3-SH2-SH3 spatial arrangement closely resembles that of Vav (41) (Table 1) . Likewise, the polypeptide encoded by pXRB55 did not activate a GBD fusion protein containing the SH3 domain of Ack, a tyrosine protein kinase that acts downstream of the Cdc42Hs protein (34) ( Table 1) . As positive VOL. 15, 1995 Vav AND POLY(rC)-SPECIFIC RNA-BINDING PROTEINS 1325 controls, both c-RAF and Grb-2 GBD fusion proteins induced transactivation of the lacZ gene when coexpressed with their known partners, RAS (47) and Sos (12), respectively (Table 1) . Visual comparison of the ␤-galactosidase activity induced by the pXRB55 clone and known pairs of interacting proteins indicated that the strength of the interactions was in the order SNF4/SNF1 Ͼ Vav SH3-SH2-SH3/pXRB55 ϭ Grb-2/Sos Ͼ c-RAF/RAS (Table 1 ). This result indicates that the Vav SH3-SH2-SH3 region and the GAD fusion protein encoded by pXRB55 interact with moderate to strong affinity. The protein encoded by pXRB55 is the human hnRNP K protein. Sequence analysis revealed that the cDNA present in the pXRB55 plasmid encoded a 292-amino-acid-long polypeptide identical to residues 171 to 463 of hnRNP K. hnRNP K was originally isolated as a poly(rC)-specific RNA-binding protein that might be implicated in the maturation of RNA and/or processes of transcriptional regulation (36, 45) . The hnRNP K sequences present in pXRB55 contain most of the functional domains described for this protein, with the exception of the amino-terminal acidic region and the first hnRNP K homology (KH) domain. pXRB55 also contains a much longer 3Ј untranslated region that extended 2 kbp farther downstream from the published sequence (data not shown). Whether this untranslated region is a differentially spliced hnRNP K mRNA remains to be determined.
Vav binds to hnRNP K in vitro. To validate the results obtained with the yeast two-hybrid system, we examined whether hnRNP K could interact with Vav in other expression systems. To this end, the cDNA fragment present in pXRB55 was subcloned into a pGEX derivative to generate a chimeric GST-hnRNP K fusion protein. This protein was purified by affinity chromatography with glutathione-coated beads and incubated with total cellular lysates of Sf9 insect cells infected with a vav-encoding baculovirus. As shown in Fig. 1A , the chimeric GST-hnRNP K protein specifically recognized the full-length mouse Vav protein. No binding was observed in mock-infected cells or in vav-infected Sf9 cells incubated with either a nonchimeric GST protein or an unrelated GST fusion protein containing the catalytic domain of the rat CDC25 Ras GDP/GTP exchange factor (Fig. 1A) . We also conducted the inverse experiment, in which a GST fusion protein containing the Vav SH3-SH2-SH3 domain was incubated with total cellular lysates obtained from mouse thymus. As illustrated in Fig.  1B , this fusion protein specifically precipitated a 68-kDa polypeptide that was recognized by anti-hnRNP K monoclonal antibodies. Taken together, these results indicate that Vav and hnRNP K specifically interact in vitro.
To determine whether this association represents a direct physical interaction between Vav and hnRNP K, we examined whether the isolated Vav SH3-SH2-SH3 protein could bind to hnRNP K immobilized on a solid support. To this end, we generated a GST-Vav SH3-SH2-SH3 protein containing a protein kinase A phosphorylation site at its C terminus. This protein was labeled with [␥- 1C , the probe specifically recognized the GST-hnRNP K protein but not other polypeptides present in the lysates, including the overexpressed GST protein alone. These results indicate that the interaction between hnRNP K and Vav is direct and does not require intermediate proteins.
Localization of hnRNP K and Vav binding sites. We next sought to identify the specific Vav sequences implicated in the binding to hnRNP K. For this purpose, we generated GST fusion proteins containing the individual SH2 and SH3 domains of Vav ( Fig. 2A) . These proteins were incubated with thymic cellular lysates, and their association with the hnRNP K protein was determined by immunoblotting with anti-hnRNP K antibodies as described above. As illustrated in Fig. 2B , the carboxy-terminal SH3 domain of Vav, but not the amino-terminal SH3 or the SH2 domain, was capable of associating with the hnRNP K protein.
To determine the Vav binding site in the hnRNP K molecule, we analyzed the binding of a 32 P-labeled GST-Vav SH3-SH2-SH3 protein to a collection of GST fusion proteins containing different regions of hnRNP K (Fig. 3A and B) . As shown in Fig. 3C (lanes b, c, d , and f), four of these GST fusion proteins were capable of interacting with the Vav probe. These fusion proteins contain either one or both of the two prolinerich sequences present in hnRNP K. The KH2 domain, the RGG-like domain, and the most carboxy-terminal regions of hnRNP K were not capable of interacting with the Vav fusion protein (Fig. 3C, lanes a and e) . These results suggest that both stretches of proline residues present in hnRNP K are the minimal structural elements required for Vav binding.
The proline-rich regions of hnRNP K are located in the central portion of the protein, flanked by the KH2 domain, the RGG-like domain, and the KH3 domain, three motifs supposedly implicated in RNA binding (Fig. 3A) . Other RNA-binding proteins also contain long stretches of proline residues (38) . These observations prompted us to determine whether the sites for the binding of RNA and Vav were overlapping. To this end, we performed Northwestern (RNA-protein) blot experiments to test the binding of the six hnRNP K fusion proteins described above to a 32 P-labeled poly(rC) probe (see Materials and Methods). As shown in Fig. 3D (lane e), the minimal region required for polyribonucleotide binding was localized to the carboxy-terminal end of hnRNP K, a region that lacks the 
A total of 1 g of pGBT derivative vectors containing the Vav SH3-SH2-SH3, the c-RAF conserved domain I (c-RAF CI), full-length Grb-2 (Grb-2), or the Ack SH3 domain (AckSH3) was cotransformed into yeast cells (YPB2 strain) with 1 g of pGAD-GH vectors containing either no insert or cDNA sequences encoding residues 171 to 463 of hnRNP K (pXRB55), wild-type RAS (c-RAS), oncogenic RAS (RASVal12), and the proline-rich region of Sos (Sos). Plasmids containing the yeast SNF4 and SNF1 proteins were used as positive controls. Four independent transfectants selected by Leu-Trp prototrophy were assayed for ␤-galactosidase activity as previously described (5).
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stretches of proline residues. Addition or exclusion of one or the two proline-rich regions did not affect the overall RNAbinding affinity to the corresponding GST fusion protein (Fig.  3D, lanes c and d) . Interestingly, neither the KH2 domain nor the RGG-like domain showed any detectable binding to RNA in this assay (Fig. 3D, lanes a and b) . These results indicate that the proline-rich regions are not required for RNA binding and that Vav and RNA bind to separate and functionally independent sites within the hnRNP K molecule.
In vivo binding of Vav and hnRNP K.
To further characterize the association between Vav and hnRNP K, we examined whether these two proteins interact in vivo. We conducted a series of coimmunoprecipitation experiments with B36-212 cells, an NIH 3T3-derived cell line that ectopically expresses high levels of the mouse Vav protein (9). B36-212 cells were harvested at different stages of the cell cycle and lysed, and the resulting extracts were immunoprecipitated with anti-hnRNP K antibodies. The resulting immunoprecipitates were probed with an antibody specific for the cysteine-rich region of Vav. As illustrated in Fig. 4A , the Vav protein readily coimmunoprecipitated with the endogenous hnRNP K in a cell cycle-independent manner. As a negative control, immunoprecipitates obtained with an unrelated monoclonal antibody elicited against ␣-tubulin gave no detectable Vav coimmunoprecipitation (Fig. 4A) . Similar results were obtained in the reverse experiment when anti-Vav immunoprecipitates were immunoblotted with anti-hnRNP K antibodies (data not shown).
Previous studies have indicated that whereas the Vav protein has a cytoplasmic localization (10), hnRNP K is located mainly in the nucleus (14, 36) . These observations raised the possibility that the observed association between these two proteins might not be physiologically relevant, with the possible exception of the mitotic stage. However, subcellular fractionation of wild-type NIH 3T3 cells indicated that hnRNP K is equally distributed between nuclear and cytoplasmic fractions (Fig. 4B) . Interestingly, overexpression of Vav in these cells induced the subcellular redistribution of hnRNP K to an almost entirely cytoplasmic localization (Fig. 4B) . These observations suggest, but do not prove, that Vav associates with hnRNP K in vivo, leading to the formation of stable cytoplasmic complexes.
Next, we examined whether Vav and hnRNP K proteins also associate in hematopoietic cells. Jurkat T cells, either nonstimulated or stimulated with antibodies against the TCR-CD4 complex (9), were lysed and immunoprecipitated with anti-Vav or anti-hnRNP K antibodies. The resulting immunocomplexes were blotted with an antibody specific for the hnRNP K protein. As shown in Fig. 4C , hnRNP K coimmunoprecipitated with the endogenous Vav protein regardless of whether the TCR complex was activated or not. As a control, immunopre- VOL. 15, 1995 Vav AND POLY(rC)-SPECIFIC RNA-BINDING PROTEINScipitates obtained with the corresponding preimmune Vav antiserum did not yield detectable hnRNP K coimmunoprecipitation (Fig. 4C) . Taken together, these results indicate that Vav and hnRNP K interact in vivo in a constitutive manner. Tissue distribution of hnRNP K. We next examined whether hnRNP K and Vav were coexpressed in mouse tissues. For this purpose, we submitted a series of tissue extracts to Western blot analysis with a monoclonal antibody raised against affinity-purified hnRNP K protein. As illustrated in Fig. 5 (upper panel), hnRNP K immunoreactivity was detected in most of the tissues surveyed, with the highest levels present in thymus, testis, spleen, brain, and liver. Other tissues such as kidney and striated muscle displayed no detectable expression of this protein. Interestingly, the hnRNP K protein displays slightly different electrophoretic mobilities depending on the tissue analyzed, a result which is consistent with a recent report describing differentially spliced forms of the hnRNP K mRNA (14) . In agreement with previous studies, Western blot analysis of the same tissues with anti-Vav antibodies shows a more limited pattern of expression, with high levels of Vav immunoreactivity detected only in hematopoietic tissues (Fig. 5,  middle panel) . As a control for the amount of protein loaded in each lane, we incubated these blots with antibodies against ␣-tubulin, a ubiquitously expressed cytoskeletal protein (Fig. 5,  lower panel) . These results indicate that whereas the pattern of expression of hnRNP K and Vav is restricted, both proteins are coexpressed in tissues of hematopoietic origin.
hnRNP K does not affect transformation of NIH 3T3 cells by ectopic expression of Vav. Constitutive activation of Vav leads to cellular transformation of NIH 3T3 cells (11, 13, 31, 32) . Therefore, we asked whether the hnRNP K protein could also induce cellular transformation when overexpressed in NIH 3T3 cells, either by itself or in association with Vav. Transfection of NIH 3T3 cells with pXRB75, a pMEX-derived expression vector containing the complete full-length hnRNP K cDNA, failed to induce detectable levels of morphologic transformation even at saturating concentrations of DNA (data not shown). Likewise, cotransfection of NIH 3T3 cells with pXRB75 and a plasmid encoding the vav proto-oncogene did not result in an increase in the number of foci.
We also investigated whether a dominant-negative mutant of hnRNP K (43) interfered with the ability of vav to transform NIH 3T3 cells. Cotransfection of a plasmid encoding this hnRNP K mutant with either the vav oncogene or the vav proto-oncogene did not result in a significant decrease in the number of foci compared with those induced by the respective vav-encoding plasmids alone (data not shown). These results suggest that hnRNP K does not play a role in the signaling pathway(s) that mediates the mitogenic properties of the Vav protein in NIH 3T3 cells.
A second poly(rC)-specific RNA-binding protein associates with the SH3-SH2-SH3 domain of Vav. The identification of hnRNP K as one of the Vav-associated proteins raised the possibility that other ribonucleoproteins may also form heterogeneous molecular complexes with Vav. To test this hypothesis, GST fusion proteins containing the SH2 and SH3 motifs of Vav ( Fig. 2A) were incubated with thymic cellular lysates, and the presence of putative ribonucleoproteins was detected by Northwestern blot analysis with labeled oligoribonucleotides. As shown in Fig. 6 (left panel) , the GST-Vav SH3-SH2-SH3 fusion protein binds to two of the four poly(rC)-binding proteins detected in the thymus. The 68-kDa protein is likely to be hnRNP K, since it has an identical electrophoretic mobility and binds specifically to the carboxy-terminal Vav SH3 domain. In contrast, the 45-kDa protein is not recognized by anti-hnRNP K antibodies and binds to the Vav SH3-SH2-SH3 region but not to any of the individual motifs (Fig. 6, left  panel) . These results indicate that the 45-kDa protein likely represents a novel RNA-binding protein rather than a proteolytic degradation product of the native hnRNP K. Northwestern blot analysis has led to the detection of this protein in other cells such as rodent fibroblast and hematopoietic cells (data not shown). As a negative control, Vav fusion proteins did not bind to any of the poly(U)-specific RNA-binding proteins present in the thymus extracts, even though this tissue contains more than nine different protein species that bind to the 32 Plabeled poly(U) probe (Fig. 6, right panel) . These results suggest that Vav is associated with two independent RNA-binding proteins with preferences for polycytosine stretches.
DISCUSSION
There is increasing evidence for a functional connection between SH2-and SH3-containing proteins and molecules im- plicated in RNA biogenesis. The first example of this relationship became apparent after the cloning of the RasGAP-associated p62 protein, a protein that contains several structural motifs common to RNA-binding proteins, including KH and ribonucleoprotein domains (49) . Indeed, subsequent biochemical studies demonstrated that p62 is a nucleic acid-binding protein with affinity for single-stranded RNA and DNA (49) . Recent studies have also shown that p68, a p62-related ribonucleoprotein, associates during mitosis with members of the Src family of tyrosine kinases, an interaction that results in its phosphorylation on tyrosine residues (19, 46) . Although the biological significance of these associations is not known, they suggest that both RasGAP and the Src tyrosine kinases can influence normal RNA metabolism by regulating the function of their associated hnRNP. Whether this regulation affects mRNA transport, mRNA affinity, or other activities remains to be determined. The current repertoire of complexes between ribonucleoproteins and SH2-and SH3-containing proteins is now further expanded by the identification of hnRNP K as one of the proteins that associates with Vav (27; this study). hnRNP K is a well-characterized RNA-binding protein, composed of KH and RGG-like domains, and is the major oligo(rC/dC)-binding protein in vertebrate cells (14, 36) . The interaction of Vav and hnRNP K was demonstrated both in vitro and in vivo, including in hematopoietic cells, the physiological source of the Vav protein, thus strongly suggesting that this association has physiological relevance.
The interaction between Vav and hnRNP K appears to be mediated by the specific recognition by the carboxy-terminal SH3 domain of Vav of two independent motifs in the hnRNP K molecule that encompass stretches of proline-rich sequences. hnRNP K does not interact with the related Vav SH3 amino-terminal motif or with Grb2, an adaptor protein that has the same spatial arrangement of SH2 and SH3 motifs as Vav. Likewise, neither Vav nor its carboxy-terminal SH3 domain recognizes the proline-rich domain of Sos, a Ras GDP/ GTP exchange factor and a physiological partner for Grb2. Moreover, we have observed that hnRNP L, a related ribonucleoprotein that contains more than eight proline residues in a single cluster (38) , does not bind to the Vav SH3-SH2-SH3 region (data not shown). These observations underscore the high degree of specificity of the interaction between Vav and hnRNP K.
It is now well documented that proline residues facilitate the binding to SH3 domains because of their tendency to induce a left-handed type II (PPII) helix conformation (50) . Polypeptides with this conformation form an extended molecular scaffold that is well suited for the proper orientation of the ligand in the long and shallow groove of the SH3 binding site (50) . PPII helices are also ideal mediators of protein-protein interactions since, because of their dependency on backbone solvation for stability, most of these motifs are located on the surfaces of their proteins (3) . Therefore, it is most likely that the proline-rich sequences RRGPPPPPGR 296 and RNLPLPPPP PPRG 317 located within the hnRNP K regions constitute the Vav SH3 anchoring sites. The apparent equal affinity of the Vav SH3 motifs to either of these sequences suggests also that hnRNP K associates with two molecules of Vav. Alternatively, hnRNP K can bind two different SH3-containing proteins at VOL. 15, 1995 Vav AND POLY(rC)-SPECIFIC RNA-BINDING PROTEINS 1329 the same time. Interestingly, it has been recently reported that the SH3 domains of Src, Fyn, and Lyn can precipitate hnRNP K in vitro (46, 48) . Although these associations await confirmation under physiological conditions, it is conceivable that hnRNP K can form a number of multiprotein complexes with different signaling molecules, perhaps facilitating the interaction of Vav with cytoplasmic tyrosine kinases. Vav may also interact with a second ribonucleoprotein of 45 kDa with specificity for stretches of polycytosine. At least two hnRNP K-related proteins of low molecular weight have been identified. These molecules, designated hnRNP X (25) and Sub2.3 (1), also contain KH domains. The functional characterization of the Sub2.3 protein has shown that it is a tissuespecific ribonucleoprotein with specificity for poly(rC) residues. Although the specificity and expression of hnRNP X are not known yet, its high level of resemblance to the Sub2.3 protein (72% identity at the amino acid level) suggests that it might represent a functional homolog of Sub2.3 and hnRNP K. Whether either of these two proteins represents the 45-kDa Vav-binding protein is under investigation. Regardless of the identity of this Vav-binding ribonucleoprotein, our observations suggest that Vav interacts specifically with poly(rC)-binding proteins. Interestingly, the Src-associated p68 protein displays a preferential specificity for poly(U) residues (46), indicating that different signaling molecules might be connected to ribonucleoproteins of differing RNA-binding specificities.
The biological significance of the interaction between Vav and poly(rC)-specific ribonucleoproteins remains to be determined. This task has been hindered by our lack of knowledge regarding the precise role of Vav in cellular signaling. Vav becomes rapidly phosphorylated on tyrosine residues upon ac- In contrast, the detection of significant levels of hnRNP K in the cytosolic fractions of NIH 3T3 cells overexpressing Vav supports the hypothesis that it might regulate in some way the subcellular distribution of this ribonucleoprotein. However, further studies will be required to establish the physiological significance of the interaction between Vav and poly(rC) ribonucleoproteins. Overexpression of hnRNP K in NIH 3T3 cells does not result in an increase of the transforming activity of Vav. Likewise, a dominant-negative mutant of hnRNP K does not interfere with vav-induced transformation. Therefore, it seems unlikely that hnRNP K is a key downstream element of the vav mitogenic pathway, at least in these cells. Recent gene-targeting studies have revealed that the vav gene is absolutely required for embryonic development. However, embryonic stem cells, which express low levels of Vav, can proliferate normally even after ablation of both vav alleles (51). These results suggest that despite its oncogenic activity in rodent fibroblasts, Vav might not play a primary role in mitogenic pathways. Thus, it is likely that hnRNP K contributes to Vav signaling in biological processes unrelated to cell proliferation.
Previous studies have demonstrated the rapid and transient interaction of Vav with a 70-kDa tyrosine-phosphorylated protein upon activation of B lymphocytes (8) . More recently, coimmunoprecipitation studies have shown that Vav binds to a high-molecular-weight GTP-binding protein (unpublished observations). In addition, the yeast two-hybrid system approach has revealed the existence of other putative Vav-binding proteins. Therefore, Vav might be a key regulatory protein for two or more distinct signaling pathways. Characterization of additional Vav-binding proteins will open the door to new insights on the physiological role of this signaling protein.
